Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.7K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

13.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
13.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Bone Disorders01:29

Bone Disorders

7.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.5K
Bone Cells and Tissue01:30

Bone Cells and Tissue

11.8K
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
11.8K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

15.4K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-dimensional assessment of macromastia: linking breast morphology to quality of life.

Frontiers in global women's health·2026
Same author

Optimizing Lung Collapse During One-Lung Ventilation: Physiological Mechanisms and Clinical Strategies: A Narrative Review.

Journal of clinical medicine·2026
Same author

Core binding factor β preserves early chondrogenic identity and prevents hypertrophic transition in cartilage organoids formation.

Cell & bioscience·2026
Same author

Predictive value of N-terminal Pro-brain Natriuretic Peptide combined with High-sensitivity Troponin-I for progression to high-risk status in acute pulmonary embolism.

Cardiology·2026
Same author

Ferroptosis in Septic Cardiomyopathy Is Alleviated by Ondansetron: The Critical Role of the HTR3A-ATF3 Axis in Mitochondrial and Oxidative Homeostasis.

Biomedicines·2026
Same author

4-Hexylresorcinol Attenuates Ethanol-Induced Hepatic and Pancreatic Injury by Modulating Metabolic Dysfunction and Endoplasmic Reticulum Stress.

Biomedicines·2026

Related Experiment Video

Updated: Mar 29, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

10.0K

Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis.

Younghoon Jeon1,2, Eunjung Heo3, Xian Jin3

  • 1Department of Anesthesiology and Pain Medicine, School of Medicine Kyungpook National University, Daegu 41944, Republic of Korea.

Marine Drugs
|March 27, 2026
PubMed
Summary

Polydeoxyribonucleotide (PDRN) promotes osteoblast differentiation for bone regeneration. This study found PDRN enhances bone formation without impacting bone-resorbing osteoclasts, suggesting its potential as a novel anabolic agent.

Keywords:
adenosine A2A receptorbone regenerationdifferentiationosteoblastosteoclastpolydeoxyribonucleotide

More Related Videos

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.8K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

2.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

10.0K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.8K
Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells
10:52

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

2.5K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Developing new anabolic agents for bone regeneration is crucial.
  • The cellular effects of Polydeoxyribonucleotide (PDRN) on bone remodeling are not fully understood.

Purpose of the Study:

  • To investigate the in vitro effects of PDRN on osteoblast and osteoclast differentiation.
  • To determine if PDRN influences key markers of bone formation and resorption.

Main Methods:

  • Osteoblast (MC3T3-E1) and osteoclast precursor differentiation were induced.
  • Cellular metabolic activity was assessed using MTS assays.
  • Gene and protein expression (Runx2, osteocalcin) were analyzed via qRT-PCR and Western blotting.
  • Osteoblast differentiation markers (ALP, Alizarin Red S) and osteoclast function (TRAP, pit formation) were evaluated.

Main Results:

  • PDRN dose-dependently increased osteoblast metabolic activity and upregulated the transcription factor Runx2.
  • PDRN significantly enhanced osteoblast differentiation, indicated by increased ALP activity, mineralized matrix deposition, and osteocalcin expression.
  • PDRN did not affect osteoclast precursor proliferation, differentiation, or resorptive activity.

Conclusions:

  • PDRN selectively promotes osteoblast differentiation and bone formation.
  • PDRN does not directly stimulate osteoclastogenesis, suggesting a favorable anabolic profile.
  • PDRN is a potential candidate for developing novel anabolic agents for bone regeneration.